BACKGROUND: Optimal levels of minerals in the diet are crucial for improving performance and immune response against the environmental stresses.OBJECTIVES: This study was conducted to evaluate the effects of water supplementation of chelated trace mineral (CTM) on growth performance, hematology, blood biochemistry, antioxidant status, and antibody response in broilers reared under heat stress condition.METHODS: A total of 240 male Ross 308 broiler chickens were randomly allocated into one of the following five treatments (each consisting of four replicates): (1) positive control (PC; thermoneutral condition), (2) negative control (NC; heat stress condition), (3) low-CTM (NC + low CTM level in tap water), (4) medium-CTM (NC + medium CTM level in tap water),  and (4) high-CTM (NC + high CTM level in tap water). The CTM levels in the tap water for the low-CTM treatment were 0.1, 0.15, 0.3, 0.4, and 0.45 mg/bird/day on days 1-10, 11-20, 21-30, 31-40, and 41-50, respectively. The respective values were 1.0, 1.5, 3.0, 4.0, and 4.5 for the medium-CTM, and 10, 15, 30, 40, and 45 mg/bird/day for the high-CTM water.RESULTS: The average weight gain during the whole experimental period in the medium-CTM treatment was higher compared to that in the negative control treatment, but lower than that in the positive control treatment (P<0.05). The heterophil/lymphocyte ratio and total antibody titers against Newcastle disease in the medium-CTM and high-CTM groups were similar to those of the broilers in the PC group, yet better (P<0.05) those of the NC group. The serum superoxide dismutase activity was also higher (P<0.05) in the high-CTM group compared to that of the NC group.CONCLUSIONS: The results suggested that the water supplementation of CTM at a moderate level (1.0, 1.5, 3.0, 4.0, and 4.5 mg/bird/day during different rearing periods) could be a strategy to ameliorate the detrimental effects of heat stress in broilers.

BACKGROUND: In order to compensate for the elimination of antibiotics from the poultry industry, finding suitable alternatives to improve the productive traits and the health of the birds is essential. Among them, naturally occurring compounds and additives are one of the best options in this regard. OBJECTIVES: The aim of this study was to evaluate the effects of sodium humate and probiotic application and their interactions on feeding broiler chicks on biochemical, immunological and blood metabolites of broiler chicks. METHODS: 336 male broiler chicks (Ross 308) were used from 1 to 42 days old. A 3×2 factorial experiment on the basis of completely randomized design was done with four replications. Experimental factors were: three sodium humate levels (0, 0.35 and 0.45% of diet) and two probiotic levels (0 and 0.02% of diet). RESULTS: The best feed conversion ratio was obtained at the finisher 1 and 2 and the whole period at the use of 0.35% of diet (P ≤0.05). The highest live weight of the last course was obtained in the treatment of 0.35% sodium humate in diet (P ≤0.05). The production index improved at a level of 0.35% of sodium humate compared to other treatments (P ≤0.05). The percentage of carcass was higher in the group receiving probiotic and sodium humate than the control group. The abdominal fat pad percentage was lower in the probiotic and humate sodium group than in the control group (P<0.05). In terms of interactions, villi length was highest in treatments receiving 0.35 of sodium humate and 0.02% of probiotic in  diet, as well as 0.45%  of sodium humate and 0.02%  probiotic in  diet (P<0.05). The highest levels of SRBC and G-type immunoglobulin were obtained in groups receiving 0.45% sodium humate and 0.02% probiotic in diet. CONCLUSIONS: In conclusion, use of sodium humate about 0.35% and probiotic 0.02% in diet of broiler chicks improves the growth performance, carcass traits  and morphological characteristics of the intestine.

An ELISA was used to detect IgG, IgM, and complement (C3) on the surface of canine erythrocytes. Erythrocytes were placed in wells of a microtitration plate and incubated with affinity purified, alkaline phosphatase-conjugated anti-canine IgG, IgM, or C3. Results of the ELISA were compared with the direct antiglobulin test (DAT) by preparing standard reference curves from canine blood type A erythrocytes that had been incubated with serial dilutions (1:2 to 1:8,192) of canine anti-A serum. The ELISA detected increased erythrocyte-bound immunoglobulin and complement at two- to fourfold dilutions greater than thoe required for positive results with the DAT. The ELISA required small sample and reagent volumes and detected lower concentrations of immune components than did the DAT.

Logistic regression was used to develop models predicting preweaning survival in 334 neonatal swine. Measured risk factors included birth weight, litter size (live born), dam parity, serum IgG concentration, serum ELISA titers recognizing common gram-negative core antigens, and serum concentrations of the third component of complement. Larger birth weights were associated with increased probability of preweaning survival. The highest mortality was observed in litters with more than 12 pigs. Pigs with serum concentration of the third component of complement (C3) in the lowest stratum, < 20% adult pooled C3 standard (APC3), had reduced mortality, compared with high (> 38% APC3) and middle (20 to 38% APC3) groups. Associations between all other variables, including total serum IgG concentration and preweaning survival were not significant. Few pigs had hypogammaglobulinemia, < 3% of the study population had serum IgG concentrations < 1 g/dl. Of all measured variables, only birth weight and dam parity were significant predictors of preweaning gain. Larger pigs and pigs born to third or greater parity dams had more preweaning gain than other pigs.

Serum antibody titers to canine parvovirus (CPV), canine adenovirus-1 (CAV-1), and canine distemper virus (CDV) were measured in dogs with known immunization status. The dogs represented 3 groups: nonvaccinated dogs less than 12 months old; vaccinated dogs less than 12 months old; and adult dogs greater than 12 months old. For practical reasons, the population from which the specimens were obtained could be considered as free from natural infection with CAV-1 and CDV. In nonvaccinated dogs less than 12 months old, antibodies against all 3 viruses were measured at the time the dogs were given their first vaccination. Altogether, 50.7% of the dogs had titer greater than or equal to 1:10 to CPV, and 26.1 and 46.2% had titer greater than or equal to 1:8 to CAV-1 and CDV, respectively. The concentration of maternal antibody seemed to be of major importance for failure of immunization with use of inactivated CPV vaccine, but not with CAV-1 and CDV vaccination. In dogs less than 12 months old and vaccinated against CPV infection with inactivated virus, only 11.5% had titer greater than or equal to 1:80. In dogs vaccinated against infectious canine hepatitis and canine distemper, 63.2 and 78.3%, respectively, had titer greater than or equal to 1:16. In adult dogs greater than 2 months old and vaccinated against CPV infection, less than 50% had titer greater than or equal to 1:80, regardless of time after vaccination. There was no significant difference in titer between vaccinated and nonvaccinated dogs. Approximately 60% of these dogs had titer greater than or equal to CAV-1 at all time intervals after vaccination. There was only a weak correlation between decrease of titers and time; this correlation could be explained by the fact that a proportion of the dogs had been vaccinated with inactivated CAV-1 virus. There was, however, no correlation between titer to CDV and time. The percentage of dogs with titer greater than or equal to 1:16 was at least 60%.